Providing business intelligence for a pharmaceutical company in Africa

A global pharmaceutical leader, dedicated to improving health care access in Africa, faced a significant challenge in understanding the illicit trade of medicines in specific countries. This illegal activity posed a threat to public health and directly impacted the company’s mission. The company sought to identify the scale, drivers, and key factors contributing to the illicit trade of medicines in the region, in order to develop a strategy to combat this issue and protect its operations.

• Conducted a thorough investigation using open-source information, human sources on the ground, and interviews with key internal stakeholders within the company.
• Analyzed the scale, dources, distribution, and demand drivers of the illicit trade in each target market to gain an understanding of the scope and dynamics of the issue.
• Assessed the legal framework in each country to determine its effectiveness in combating the trade, including the role of law enforcement and regulatory bodies.
• Evaluated the political will to address the issue in each market, identifying key stakeholders, such as government officials and industry leaders, who could be engaged to help drive change.

Our detailed intelligence report provided the company with actionable insights and a roadmap tailored to each market. Our recommendations included both country-specific and regional strategies, enabling the company to take a more coordinated and impactful approach to combating the illicit trade of medicines. As a result, the company was better equipped to mitigate the risks posed by illegal trade, safeguard its business interests, and continue its mission to improve health care access across Africa.